Stockholders approve reverse stock split and director elections at Intelligent Bio annual meeting

Proposal 1. The election of five directors, each to serve until the next annual meeting of stockholders, or until each successor is duly elected and qualified. Nominee Votes For Votes Withheld Broker Non-Votes Stephen Boyages 1,549,332 204,576 1,298,111 Lawrence Fisher 1,547,779 206,129 1,298,111 Jonathan Hurd 1,547,504 206,404 1,298,111 Jason Isenberg 1,547,783 206,125 1,298,111 Christopher Towers 1,547,443 206,465 1,298,111

Proposal 2. The approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio not less than 1-for-2 and not greater than 1-for-12, with the exact ratio to be set within that range at the discretion of our Board of Directors without further approval or authorization of our stockholders (the “Reverse Stock Split Proposal”). Votes For Votes Against Abstain Broker Non-Votes 2,456,199 590,016 5,804 0

Proposal 3. The approval of the amendment of the Company’s 2019 Long Term Incentive Plan (the “2019 Plan”) to increase the number of shares of common stock authorized for issuance under the 2019 Plan by 1,475,000 shares and to increase the limit on the maximum number of shares underlying awards to any non-employee director in any year to 15,000 shares in any year (the “2019 Plan Amendment Proposal”). Votes For Votes Against Abstain Broker Non-Votes 1,515,129 235,051 3,728 1,298,111